Skip to main content

World Allergy Week

It's World Allergy Week! Although we don't believe the two are related, I have horrible allergies. They certainly don't do my other health concerns any favors! We tend to think of allergies as being a "minor" problem. I guess that's because the usual medications work so well for most people. For me, however, I take three to four allergy meds all the time, and when things are bad (like this time of year) even that doesn't cut it. So, thought I'd share the following press release. It has some interesting allergy statistics. 



EMBARGOED FOR RELEASE UNTIL 16 APRIL 2012  
NEWS RELEASE  
16 April 2012 
Contact:  
Sofia Dorsano, sdorsano@worldallergy.org
Note to media: See www.worldallergy.org/worldallergyweek  




Complexity of allergic disease impacts patient quality of life 
World Allergy Organization calls for integrated approaches to patient care as the global burden of allergic 
diseases and asthma continues to rise to epidemic proportions


MILWAUKEE – The World Allergy Organization will present data on the marked global increase of allergic
diseases, highlighting that allergies are becoming more severe and complex and that the heaviest burden 
is on children and young adults. Allergy interacts with many other environmental factors such as pollutants, infections, lifestyle, and diet that increase the impact on chronic disease. WAO will address the need for increased disease awareness, improved patient care, better healthcare delivery and a focus onpreventative strategies, during a World Allergy Week 2012 press conference at 9:00 am EDT today. 


Approximately 30 to 40 percent of the world’s population suffers from allergic diseases, and the prevalence is escalating to epidemic proportions. According to the World Health Organization (WHO), an estimated 300 million individuals have asthma worldwide, a figure that could increase to 400 million by 2025 if trends continue. Allergic rhinitis, which is a risk factor for asthma, affects 400 million people annually, and food allergies affect about 200 to 250 million. An estimated 250,000 avoidable deaths from 
asthma occur each year. Prof. Marek Kowalski, Chair of the World Allergy Week Steering Committee, said that “The increase in multiple allergies occurring in a single patient is making the global burden even more complex, and an integrated approach to diagnosis and treatment of allergies is required. Rhinitis (“allergies”), allergic conjunctivitis (itchy, red and watery eyes), and asthma occurring together in the same patient, or rhinitis, asthma, and food allergies, are examples of complex allergies that commonly
manifest together in patients with allergies.” 


As the prevalence of allergic disease rises in countries around the world regardless of their economic
status, so do the socioeconomic costs both direct (interference with breathing during day or night, 
emergency department visits, hospitalizations) and indirect (reduced quality of life, reduced work productivity and absenteeism). Prof. Ruby Pawankar, WAO President, said “WAO recommends (1) increased, availability and accessibility to allergy diagnosis and therapies (2) increased resources dedicated to advanced research toward preventive strategies to increase tolerance to allergens and slow disease progression and (3) global partnerships of multi-disciplinary teams, involving clinicians, academia, 
patient representatives, and industry. The common goal is to reduce the burden of allergic diseases and develop cost-effective, innovative preventive strategies and a more integrated, holistic approach to treatment. These efforts can thereby prevent premature and unwanted deaths and improve quality of life.” 


About the World Allergy Organization 
The World Allergy Organization (WAO) is an international alliance of 89 regional and national allergy, 
asthma and immunology societies. Through collaboration with its Member Societies WAO provides a wide 
range of educational and outreach programs, symposia and lectureships to allergists/immunologists 
around the world and conducts initiatives related to clinical practice, service provision, and physical 
training in order to better understand and address the challenges facing allergists/immunologists 
worldwide. For more information, visit www.worldallergy.org

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria